Harrow (HROW) Common Equity (2010 - 2026)
Harrow (HROW) posted quarterly Common Equity of $28.7 million for Q1 2026, down 48.83% year-over-year from $56.1 million in Q1 2025, and down 44.89% quarter-over-quarter from $52.1 million in Q4 2025.
Harrow (HROW) Common Equity (2010 - 2026) Analysis & Trends
Harrow's Common Equity history runs 17 years deep, the most recent figure standing at $28.7 million for Q1 2026.
- In Q1 2026, Common Equity fell 48.83% year-over-year to $28.7 million; the TTM figure through Mar 2026 stood at $28.7 million (down 48.83% YoY), while the FY2025 annual figure was $52.1 million, down 24.83% from the prior year.
- Common Equity for Q1 2026 stood at $28.7 million, down from $52.1 million in the prior quarter.
- The five-year high for Common Equity was $75.4 million in Q3 2023, with the low at $862000.0 in Q3 2022.
- The 5-year median for Common Equity is $49.3 million (2025), against an average of $41.8 million.
- The sharpest annual moves came in 2022 and 2023: Common Equity sank 94.69% in 2022, then surged 8647.33% in 2023.
- Harrow's Common Equity stood at $27.2 million in 2022, then jumped by 158.48% to $70.4 million in 2023, then retreated by 1.58% to $69.3 million in 2024, then dropped by 24.83% to $52.1 million in 2025, then slumped by 44.89% to $28.7 million in 2026.
- Business Quant data shows HROW's Common Equity at $28.7 million in Q1 2026, $52.1 million in Q4 2025, and $47.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 4.05 Bn |
| 10 | Harrow | 1.55 Bn | 1.46 Bn | 50.36 Mn | 15.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.20 Mn |
| Mar 31, 2026 | 28.71 Mn |
| Dec 31, 2025 | 52.09 Mn |
| Sep 30, 2025 | 47.02 Mn |
| Jun 30, 2025 | 49.30 Mn |
| Mar 31, 2025 | 56.10 Mn |
| Dec 31, 2024 | 69.30 Mn |
| Sep 30, 2024 | 57.62 Mn |
| Jun 30, 2024 | 58.18 Mn |
| Mar 31, 2024 | 60.21 Mn |
| Dec 31, 2023 | 70.41 Mn |
| Sep 30, 2023 | 75.40 Mn |
| Jun 30, 2023 | 22.05 Mn |
| Mar 31, 2023 | 21.53 Mn |
| Dec 31, 2022 | 27.24 Mn |
| Sep 30, 2022 | 862,000.00 |
| Jun 30, 2022 | 5.39 Mn |
| Mar 31, 2022 | 9.74 Mn |
| Dec 31, 2021 | 10.93 Mn |
| Sep 30, 2021 | 16.23 Mn |